2009-2010 U.S. News & World Report Best U.S. Hospital Rankings

Today, U.S. News & World Report issued its 2009-2010 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment; Brigham and Women’s Hospital is rated #1 in gynecology; and Johns Hopkins is rated #1 overall based upon all medical specialties.

If you would like more information regarding the 2009-2010 U.S. News & World Report best U.S. hospital rankings, click here. To better understand how U.S. News & World Report ranked the hospitals in each specialty, read America’s Best Hospitals: Here’s How We Selected Them – Deaths, reputation, and patient safety were among the factors the rankings took into account, written by U.S. News & World Report’s Avery Comarow.  If you would like to review the current U.S. News & World Report America’s Best Children’s Hospitals list, click here.

Top 10 U.S. Hospitals: Cancer

Top 10 U.S. Hospitals: Gynecology

Top 10 U.S. Hospitals (highest scores in at least six medical specialties)

1. Univ. of Texas M.D. Anderson Cancer Center, Houston, Texas Brigham and Women’s Hospital, Boston, Massachusetts Johns Hopkins Hospital, Baltimore, Maryland
2. Memorial Sloan-Kettering Cancer Center, New York, New York Johns Hopkins Hospital, Baltimore, Maryland Mayo Clinic, Rochester, Minnesota
3. Johns Hopkins Hospital, Baltimore, Maryland Mayo Clinic, Rochester, Minnesota Ronald Reagan UCLA Medical Center, Los Angeles
4. Mayo Clinic, Rochester, Minnesota Duke University Medical Center, Durham, North Carolina Cleveland Clinic, Cleveland, Ohio
5. Dana-Farber Cancer Institute, Boston, Massachusetts Univ. of California, San Francisco (UCSF) Medical Center Massachusetts General Hospital, Boston, Massachusetts
6. University of Washington Medical Center, Seattle, Washington Cleveland Clinic, Cleveland, Ohio New York-Presbyterian Univ. Hospital of Columbia & Cornell, New York, New York
7. Massachusetts General Hospital, Boston, Massachusetts Magee-Womens Hospital of Univ. of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Univ. of California, San Francisco (UCSF) Medical Center
8. Univ. of California, San Francisco (UCSF) Medical Center New York-Presbyterian Univ. Hospital of Columbia & Cornell, New York, New York Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
9. Duke University Medical Center, Durham, North Carolina Massachusetts General Hospital, Boston, Massachusetts Barnes-Jewish Hospital/Washington University, St. Louis
10. Stanford Hospital and Clinics, Stanford, California Ronald Reagan UCLA Medical Center, Los Angeles Brigham and Women’s Hospital, Boston, Massachusetts

22 thoughts on “2009-2010 U.S. News & World Report Best U.S. Hospital Rankings

  1. My mom was just diagnosed w/ stage 4 ovarian cancer. I am in different state from her & have yet 2 be able 2 go till end of week. She has mentioned hospitals in PA. She lives in NJ. After doing research online I see that it is best 4 her 2 c a gyno cancer Dr. I am new 2 this diagnosis & feel that I need 2 try 2 convince her 2 go 2 a woman’s cancer center 4 her best chance of fighting this. Any advice or help w/ hospitals near her that will best help her survive as long as possible would be greatly appreciated.
    Thank you,


    • Dear Brandi,

      By way of introduction, my name is Paul Cacciatore and I am the founder of Libby’s H*O*P*E*. We are so sorry to hear about your mom’s recent diagnosis, but we are more than happy to assist you with some options for treatment centers. The two most important decisions that an ovarian cancer survivor can make upon diagnosis are the following: (i) where to be treated, and (ii) who to be treated by.

      You already discovered the single most important issue in connection with your mother’s treatment: use of a board-certified, gynecologic oncologist who performs surgery at a high-quality, high-volume medical center. Medical studies have shown that use of a gyn-onc actually increases survival. We generally recommend the use of a NCI-designated cancer center or a National Comprehensive Cancer Network member.

      There are many good cancer centers located in New York, New Jersey, and Pennsylvania. We will contact you via private email to provide you with additional suggestions regarding potential treatment centers. We are here to assist you in whatever role you deem appropriate, so keep the faith and keep educating yourself regarding the treatment of ovarian cancer. Another critical weapon in the fight against ovarian cancer is knowledge obtained by a family patient advocate on behalf of a loved one who is fighting the disease.

      We will contact you later tonight or tomorrow regarding our recommendations. Please know that your mother and your entire family are in our thoughts and prayers.

      Best regards,



  2. Paul,
    My Mother has been diagnosed with a complex cystic mass on her ovary. The size is approximately 2″ in diameter. She has had a Ultra Sound, CRT and Ova 1 blood test. The Ultra Sound and CRT have been inconclusive and the Ova 1 blood test has come back with a score of 4.6 on scale of 1 to 10. The cut off for low/high is (>4.4). She is post Menopausal (74) and has diabetes. The diabetes can inflate her Ova 1 score.

    We have found Dr. Rader in Milwaukee (rated in upper 1% by US News) were my Mom currently lives. Is Dr Rader the best in the Milwaukee area according to your rankings? How is the post operative treatment at Froedert Hospital in Milwaukee rated?

    I also live near Chicago. Should I get her down to Chicago and find the top Doctors at University of Chicago, Northwestern, Loyola or Rush now? Which Doctor and facility is the best in Chicago for ovarian cancer?

    Should we start (biopsy) in Milwaukee and move her to Chicago if results are malignant? Is changing Doctors after initial operation (move from Milwaukee to Chicago) normal or hard to do? We can get her in about 10 days to 2 weeks quicker in Milwaukee. Is time initially more important or is getting the best Doctors and Treatment Centers at the start (Chicago vs Milwaukee) the most important first step?

    Time is of the essence, your help will be greatly appreciated.



    • Tom,

      Thank you for your inquiry. Please know that our thoughts and prayers are with your mother, as well as your entire family. We will respond today or tomorrow to your inquiry through private email response. It is actually easier for us to respond by private email because our longer comment responses cannot be saved prior to posting, and therefore, must be drafted in one sitting.

      We fully understand that time is of the essence and we look forward to working with you regarding your mother’s situation.

      Best regards,

      Paul Cacciatore
      Founder, Libby’s H*O*P*E*


  3. I am finding fewewr and fewer physicians in Louisiana. I haveovarian cancer and on my 3rd do round with chemo. I had a month of radiation last year that worked. i now have insurance, what and who do you see as the best in louisiana to treat ovarian cancer,


    • Dear Tina,

      Thank you for your inquiry. We normally recommend that ovarian cancer survivors see a gynecologic oncologist who is associated with an institution that is a NCI-designated cancer center and/or a National Comprehensive Cancer Network (NCCN) member. Unfortunately, there are no NCI-designated cancer centers or NCCN member institutions located in Louisiana. If you were willing to travel for treatment, we highly recommend the University of Texas M.D. Anderson Cancer Center and the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center. If you are willing to travel to either location, please let us know and will we provide the names of a few gynecologic oncologists at both locations.

      If you are unable to travel for treatment, we would recommend two Louisiana gynecologic oncologists (of course, without knowing your proximity to their locations).

      The first doctor is Richard Kline, M.D. Dr. Kline earned his medical degree from Louisiana State University (LSU), completed his residency at the Ochsner Medical Center and completed his fellowship in gynecologic oncology at the University of Texas M.D. Anderson Cancer Center and Tumor Institute in Houston, Texas. He is board certified in obstetrics and gynecology and gynecologic oncology and has been on staff at Ochsner since 1986 when he became Ochsner’s first staff gynecologic oncologist. Dr. Kline is a recognized expert in gynecologic oncology having been named as one of the top gynecologic oncologists in the city by the New Orleans Magazine in 2009. His special interest and expertise is the treatment of malignancies of the female reproductive organs including cancer of the ovary, uterus, cervix, vagina and vulva, including radical pelvic surgery and chemotherapy. Dr. Kline is also a prolific researcher and is an investigator for the National Cancer Institute’s Gynecologic Oncology Group. He has written many articles for scientific publications including two book chapters. Dr. Kline is listed as a “Top Doctor” under the specialty of gynecologic oncology (300 gynecologic oncologists listed nationwide) by U.S. News & World Report. Dr. Kline is listed in U.S. News & World Report as among the top 1% of gynecologic oncologists in the nation. Dr. Kline is located in New Orleans.

      The second doctor is Patricia Braly, M.D. Dr. Braly has locations in Covington and Metairie. Dr. Braly is associated with Women’s Cancer Care. You can find her biography on the Women’s Cancer Care website homepage. She received her medical training from University of California (UC), Irvine and is board certified in obstetrics and gynecology and gynecologic oncology. Dr. Braly, like Dr. Kline, is listed as a “Top Doctor” under the specialty of gynecologic oncology (300 gynecologic oncologists listed nationwide) by U.S. News & World Report. Dr. Braly is also listed in U.S. News & World Report as among the top 1% of gynecologic oncologists in the nation.

      If you decide to seek treatment locally, we suggest that you seek a second treatment opinion from M.D. Anderson. At this point, you may want access to a facility that offers a range of ovarian cancer clinical trials. Dr. Kline will also have a good working knowledge of ovarian cancer clinical trials because he is an investigator with the GOG as noted above. If, at some point, you decide to pursue potential ovarian cancer or solid tumor clinical trial drugs, we can assist you in identifying trials within your preferred geographic treatment area which you can discuss with your doctor.

      Tina, if you have any further questions, please feel free to contact us through the “Contact” tab located on the Libby’s H*O*P*E* website homepage. Please know that our thoughts and prayers are with you and your family as you move ahead in your fight. Keep the faith and don’t let anyone take your hope away.

      Best regards,

      Paul Cacciatore
      Founder, Libby’s H*O*P*E*


  4. Paul: Are you familiar with the Ovarian Cancer Vaccine Trial using CVac? Cvac Trial is sponsored by Prima Bio Med Ltd of Australia. Can you share the progress with us.

    Thank you!


    • Dear Eugene,

      Please forgive our inordinate delay in responding to your recent comment. We are familiar with the ongoing clinical testing of the MUC-1 dendritic cell vaccine known as “CVac.” As far as we know, the phase IIb CVac clinical study with respect to ovarian cancer patients in remission is still ongoing. The study is being conducted in the U.S. and Australia. For a copy of the 2010 American Society of Clinical Oncology presentation, click here. For a copy of the phase IIb CVac clinical trial summary, click here.

      The phase IIa CVac study enrolled 28 patients (21 evaluable) with incurable ovarian cancer (life expectancy at least 6 months), and rising CA125 levels defined as at least 25% over baseline within one month confirming rapidly progressing disease. Patients had received multiple courses of chemotherapy/ radiotherapy. The patients received 3 injections of CVac over a ten week period, followed by 4 injections at 10 week intervals. The investigators reported that 21% of patients responded to therapy (CA-125 reduction or prolonged stabilization) and 47% of patients had disease stabilization (CA-125 remained stable). There was no CVac therapy-related toxicity reported and progression free survival averaged 127 days (95% confidence limits 96 to 219 days).

      In the earlier phase I study, an immune system response produced T-cell responses in all patients, with evidence of tumor stabilization in 2 of the 10 advanced cancer patients treated. The two responding patients had ovarian and renal cancer, respectively. These two patients received ongoing therapy for >40months. Safety of the vaccine was also demonstrated.

      The company hopes to complete enrollment for the phase IIb study this year (Q3 2010). It also hopes to open a large 800 ovarian cancer patient phase III randomized, double-blinded study in Q3 2010 with locations in the U.S., Europe, Australia, and New Zealand. The intention behind the phase III study is to establish definitive progression free survival and overall survival data. To review the BioMed’s July 2011 investor presentation, click here (Adobe Reader PDF document).

      For our readers who are interested in learning more about the CVac vaccine, please visit http://www.primabiomed.com.au/products/cvac.php.

      We hope that you find the information above helpful. If you have any additional questions, please feel free to contact us.

      Best regards,



  5. My wife has just been diagnosed with stage 3, possibly stage 4 ovarian cancer. We live in Overland Park, KS, near Kansas City, MO. What would be your recommendation for a top cancer center near us? We are considering making an appointment at the University of Kansas Cancer Center. What do you think of them? Any advice would be appreciated.

    Thank you very much.


    • Dear James,

      We are sorry to hear about your wife’s recent diagnosis. Our thoughts and prayers are with you and your family. The biggest factor impacting survival in ovarian cancer is the performance of surgery by a board-certified (rather than “board eligible”) gynecologic oncologist at a high volume gynecologic cancer surgery center. The ability of your wife’s doctor to perform a thorough surgery where only 1 cm or less of visible cancer remains is critical. So the experience of the board-certified gynecologic oncologist is critical. Try to find a gynecologic oncologists who spends the vast majority of his or her time within the area of gynecologic oncology rather than general OBGYN practice. Surgical removal of as much visible cancer as possible is still the most important weapon against ovarian cancer, so talk to your wife’s doctor about what he or she will do to ensure “optimal” surgery.

      If you live close to a National Cancer Institute (NCI)-designated cancer center or a facility that is a member of the National Comprehensive Cancer Network (NCCN), those centers may be preferable. Unfortunately, it appears that you do not live close to either a NCI-designated cancer center or a NCCN member facility.

      To identify additional gynecologic oncologists, you can use the Women’s Cancer Network, which is affiliated with the Society of Gynecologic Oncologists (SGO). Click here to use the SGO affiliated website locator. To view a list of gynecologic oncologists located in Missouri, click here. To view a list of gynecologic oncologists located in Kansas, click here.

      Additional ideas include the following: (i) contact the director of a local gynecologic oncology department at a local medical school and obtain referrals, (ii) review the Kansas/Missouri resources listed by the Vicki Welsh Fund (click here), and (iii) make a request for referrals on the Ovarian Cancer National Alliance message board located at Inspire.com.

      Based on the U.S. News & World Report rankings from last year, University of Kansas Cancer Center and St. Luke’s appear to be ranked #1 & #2, respectively, in gynecology. University of Kansas Cancer Center is the only facility that is listed as “high-performing” in both cancer and gynecology. We have no first-hand knowledge of either UKCC or St. Luke’s. Click here to view a list of gyencologic oncologists available at UKCC. Please be aware that the U.S. News & World Report rankings are generally helpful, but not definitive, because you are looking for a highly skilled board-certified gynecologic oncologist who performs a large number of surgeries per year at a reputable center. So, the reputation of the facility is important, but so is the skill of the individual surgeon.

      You may want to consider a second opinion (potentially at a NCI-designated or NCCN member facility) regarding your wife’s case after visiting a local facility, so you can compare the level of expertise.

      James, we hope that the information above is helpful. If you have any additional questions, please feel free to contact us.

      Best regards,



  6. I am an Ashkenazie Jew and my two maternal aunts had breast cancer. I would like to get a BRCA test. I live on the border of Virginia and North Carolina. The large university hospitala closest to me are Duke and Wake Forest (Baptist Hospital). Univ of Virginia is further, but I can go there too. Do you know which of these hospitals is the better choice for BRCA counseling, testing and follow-up counseling?


    • Dear Eydie,

      Given your Eastern European Jewish ancestry, and the family history of breast cancer, you are doing the right thing in seeking genetic counseling. Among Ashkenazi Jews, the lifetime risk of ovarian cancer is 1 in 40. Both Duke and Wake Forest are excellent facilities. Both facilities should be able to provide adequate genetic screening. You may also want to check out the FORCE (Facing Our Risk of Cancer Empowered) website for additional information related to finding a genetics specialist (see http://www.facingourrisk.org/info_research/hereditary-cancer/risk/index.php). It is important to speak with a genetic counselor prior to being tested for BRCA gene mutations, because the specialist can best address whether testing is warranted based on the entirety of your factual case (including a complete family history).

      We hope that the information above is helpful. If you have any additional questions, please let us know.

      Best regards,



  7. I’m from Nashville but grew up in Kannapolis, North Carolina. I always knew Duke was a good hospital but by the time I was diagnosised with ovarian cancer I had moved back to the Nashville area so I go to Vanderbilt. I had my first surgery on Dec.23, 2009 and I just had my second surgery in April 19, 2011. I’m doing good. In fact, my recover was almost pain free (never had to take one pain pill). I really like my doctor (Dr. Marta Crispens) and Vanderbilt has been good to me. I lost my job in 2008 and haven’t been able to find one. I don’t have insurance but Vanderbilt did my last surgery free of charge. I’m so grateful to them for helping me the way that they did. If I move back to North Carolina I would go to Duke but I’m happy with the doctor I have now. I also lived in Iowa for a short time and the University of Iowa is pretty good too.


    • Dear AJ,

      Thank you for your comment. We are thrilled to hear that your second ovarian cancer surgery went well. We are sorry to hear about your job loss, but it is wonderful that Vanderbilt assisted you with your surgery in terms of cost. I wish more cancer centers around the U.S. would provide more pro bono work for those who have recently lost employment. Duke also has a fantastic gynecologic cancer program which is led by Dr. Andrew Berchuck, the Director of the Division of Gynecologic Oncology at the Duke University Medical Center. It sounds like you are in great hands and quickly on the mend. You are in our thoughts and prayers as you move ahead on the road to full recovery.

      All the best,



  8. Hi, my mom was just diagnosed with Stage 3 ovarian cancer. We live near Palo Alto. How is Stanford for care? We were referred to Nelson Teng, MD. Thanks


    • Dear Ash,

      We are so sorry to hear about your mom’s ovarian cancer diagnosis. Please let her know that our thoughts and prayers are with her. Given your location, either Stanford or UCSF would be good choices for treatment, although Stanford is closer to you. Both cancer centers are NCI-designated cancer centers and members of the NCCN network. In short, both locations should be able to provide high quality care.

      At initial diagnosis, keep in mind that “optimal” cytoreductive surgery by a skilled gynecologic oncologist still remains the single biggest weapon against ovarian cancer. This single fact has been linked to improved survival in medical studies. You may also want to ask Dr. Teng whether or not your mom is a candidate for intraperitoneal chemotherapy or HIPEC as part of her initial 1st line treatment.

      Prior to surgery, you may also want to ask Dr. Teng if he is open to obtaining samples during 1st line surgery which can be used for chemosensitivity testing and genetic testing. The reason to address this issue with Dr. Teng now, is that the optimal form of both kinds of testing requires live surgical samples (not stored samples). Please be aware that most main stream gynecologic oncologists do not endorse these forms of testing due to the lack of large scale, phase III clinical trial results which support an association between such testing and an increase in overall survival. We believe that both forms of testing, used in tandem, place your doctor in the best possible factual position, based on current technology, to recommend treatment options for an ovarian cancer patient based upon her cancer’s unique molecular and genetic characteristics.

      We hope this information is helpful. As always, if you have additional questions, please feel free to contact us.

      Best regards,



  9. What is THE BEST HOSPTIAL OVERALL for Stage III3/Stage 4 Ovarian Cancer in the country? Full removal of everything (surgery) has already been done. My mom died of this, 15 years ago, at age 53. I am 44 and just diagnosed, after this surgery as above stage. I see that according to US News and World, Bringham Young was #1 for OBGYN but when I checked their site, it seems breast, not ovarian, is more their specialty, although I could be wrong. Any and all suggestions are greatly appreciated!!!


    • Hi Hopeful,

      The rankings can sometimes be confusing, and they are by no means definitive. As you can see, M.D. Anderson is ranked #1 in cancer. If you can provide us with your general location (i.e., state), we can try to find experts who are close to your location. Without any location, and knowing that you are a young ovarian cancer survivor, I would recommend that you get an opinion from the M.D. Anderson Cancer Center, through referral by your doctor if possible. Have your doctor speak with Maurie Markman, M.D. as an initial contact. I am sure that Dr. Markman can provide you and your doctor with an appropriate referral within M.D. Anderson. I also believe that Massachusetts General Hospital in Boston is doing great work. If your doctor needs an initial contact at Mass. Gen., I would recommend Michael Birrer, M.D., Ph.D. as an initial point of contact. Dr. Birrer can provide an appropriate referral at Mass. Gen. or Dana-Farber.

      If these two cancer centers are located too far away from you, let us know your state of residency and we will identify someone closer. There are many good NCI-designated and NCCN-designated cancer centers around the country.

      In your case, there are a few factors to take into consideration.

      First, as part of your initial treatment, did you receive intraperitoneal (IP) chemotherapy along with intravenous (IV) chemotherapy? IP chemo treatment should be considered by your doctor. Also, your doctor should try to treat your cancer based on your stage, amount of residual disease after surgery, and specific type of tumor (e.g., serous, clear cell, endometrioid, mucinous, etc.)

      Second, you should be tested for BRCA gene mutations (which increase risk for breast and ovarian cancer through heredity) because your mom died from this disease. Hopefully, your doctor has already tested you for these mutations. The potential existence of these mutations raises an important treatment issue — the use of so-called PARP inhibitors. There is some evidence that women with BRCA gene mutations respond well to this class of drugs. See “PARP Inhibitor Olaparib Benefits Women With Inherited Ovarian Cancer Based Upon Platinum Drug Sensitivity.”

      Third, you want a cancer center that provides a wide variety of ovarian cancer and solid tumor clinical trials. This fact is important because you are Stage IIIC/IV. You always want to have the ability to enter a potentially helpful clinical trial which is using a novel therapy.

      The information above is a good start. If you have additional questions after reviewing our reply, please feel free to contact us. Our thoughts and prayers are with you in this fight.

      Best regards, Paul


  10. How do you arrange an appt at one of these hospital? Mayo or Duke. My friend just keeps having repeated chemo but the 125 test stays above normal I think it is time for the next step.


    • Hi Bonnie,

      If your friend believes that something more can be done, a second, and even third opinion can help. For the Mayo Clinic contact information, click here. As you probably know, the Mayo Clinic has locations in Minnesota, Florida and Arizona. For the Duke Comprehensive Cancer Center (gynecologic oncology), click here. If you or your friend have additional questions, please feel free to contact us.

      Best regards, Paul


  11. I have found that as long as your physician is willing to consult with the top hospitals, you will be in good hands in even smaller settings. Those settings tend to know what they cannot handle. (Those that won’t look at research or talk to other doctors, I would run from.)


    • MLO,

      Thank you for taking the time to stop by. Your weblog, http://www.mloknitting.com, is great because your writing covers a variety of topics and is truly honest.

      I understand your comment in the context that such an approach worked for you. I am not sure that such an approach will work for all women. I am aware of remarkable success stories and disasters in large and small settings. I do not think there is a hard & fast rule. I agree that it is critical for each woman to be proactive and continually ask her doctor “why?” I agree that a doctor that won’t look at patient research (assuming it is current, relevant, and well-organized) should create a moment of pause. Unfortunately, there are many patients who do not have the skills, time and/or intestinal fortitude to research their disease and challenge a doctor while in the midst of fighting cancer. In addition, many of those patients also do not have a family member or friend to act as an advocate on their behalf.

      There are a many critical issues that a woman facing an ovarian cancer diagnosis may have to address in the course of her treatment. First, I believe that treatment by a board-certified gynecologic oncologist is best. Second, we know that expert cytoreduction (debulking) surgery increases survival (see Bristow et. al., Johns Hopkins) and represents one of the best weapons against ovarian cancer. Third, we know that ovarian cancer generally responds well to chemo initially (with the exception of a few subtypes such as clear cell) but may become resistant to such treatment later. Fourth, if the first few mainstream lines of treatment are not successful, you require a doctor with knowledge of therapies that are in the clinical development pipeline (i.e., clinical trial drug and treatment knowledge), including the priority and sequence that should be assigned to multiple trials (e.g., possibly based on the tumor’s unique genetic characteristics, or entry/exclusion criteria). Needless to say, this is a lot of territory for a small group to cover, assuming the woman progresses ultimately through multiple levels of treatment. I am a fan of making sure that a treatment facility can address all of these issues prior to the start of treatment, even if the woman does not ultimately require all of these services. The facilities that tend to have all of these resources in one place are the NCI-designated cancer centers and the NCCN member institutions, many of which are highly ranked in the complete 2009-2010 U.S. News & World Best Hospitals Listing. These same centers usually have a team of doctors review difficult patient cases even though the patient may only have face-to-face contact with one doctor — a Socratic Method approach of sorts. Also, many of these centers have excellent translational research programs where clinical trials are conducted based upon research, but real patient experiences are taken into account and reviewed by those conducting the research. This structure creates an efficient flow of research information from lab to bedside and back again.

      MLO, thanks again for the comment, and we wish you continued success with your weblog and in your battle against ovarian cancer. I encourage all of our readers to stop by and check out MLO’s blog.

      Best, Paul


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s